|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 115.79 USD | -0.24% |
|
-6.49% | +10.00% |
| 03-06 | Top pharma companies racing to launch a weight-loss pill | RE |
| 03-04 | Health Rounds: Laser treatment before immunotherapy helps brain cancer patients live longer | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Cash And Equivalents | 8.1B | 12.69B | 6.84B | 13.24B | 14.56B | |||||
Short Term Investments | - | 498M | 252M | 447M | - | |||||
Trading Asset Securities, Total | 14M | - | - | - | - | |||||
Total Cash And Short Term Investments | 8.11B | 13.19B | 7.09B | 13.69B | 14.56B | |||||
Accounts Receivable, Total | 10.78B | 10.62B | 11.7B | 11.12B | 12.69B | |||||
Other Receivables | - | - | - | 8M | 15M | |||||
Total Receivables | 10.78B | 10.62B | 11.7B | 11.13B | 12.71B | |||||
Inventory | 5.95B | 5.91B | 6.36B | 6.11B | 6.66B | |||||
Restricted Cash | - | 79M | 68M | 76M | 125M | |||||
Other Current Assets, Total | 5.42B | 5.92B | 6.94B | 7.78B | 9.46B | |||||
Total Current Assets | 30.27B | 35.72B | 32.17B | 38.78B | 43.52B | |||||
Gross Property Plant And Equipment | 39.06B | 40.75B | 42.75B | 44.3B | 48.74B | |||||
Accumulated Depreciation | -18.19B | -17.98B | -18.27B | -19.16B | -21.91B | |||||
Net Property Plant And Equipment | 20.86B | 22.77B | 24.49B | 25.15B | 26.82B | |||||
Long-term Investments | 966M | 1.85B | 1.56B | 1.61B | 2.08B | |||||
Goodwill | 21.26B | 21.2B | 21.2B | 21.67B | 21.58B | |||||
Other Intangibles, Total | 22.93B | 20.27B | 18.01B | 16.37B | 26.68B | |||||
Accounts Receivable Long-Term | - | - | - | - | 125M | |||||
Deferred Tax Assets Long-Term | 692M | 503M | 1.97B | 3.6B | 2.6B | |||||
Other Long-Term Assets, Total | 8.71B | 6.85B | 7.28B | 9.93B | 13.46B | |||||
Total Assets | 106B | 109B | 107B | 117B | 137B | |||||
Liabilities | ||||||||||
Accounts Payable, Total | 6.39B | 5.04B | 4.97B | 5B | 4.52B | |||||
Accrued Expenses, Total | 11.49B | 12.63B | 14.19B | 13.87B | 13.74B | |||||
Short-term Borrowings | 112M | 246M | 72M | 149M | 289M | |||||
Current Portion of Long-Term Debt | 2.3B | 1.7B | 1.3B | 2.5B | 2.3B | |||||
Current Portion of Leases | 304M | 281M | 285M | 282M | 294M | |||||
Current Income Taxes Payable | 1.22B | 1.99B | 2.65B | 3.91B | 4.73B | |||||
Other Current Liabilities | 2.05B | 2.36B | 2.23B | 2.71B | 2.46B | |||||
Total Current Liabilities | 23.87B | 24.24B | 25.69B | 28.42B | 28.33B | |||||
Long-Term Debt | 30.69B | 28.74B | 33.68B | 34.46B | 46.75B | |||||
Long-Term Leases | 1.22B | 1.01B | 928M | 877M | 901M | |||||
Pension & Other Post Retirement Benefits | 1.87B | 1.22B | 1.23B | 939M | 839M | |||||
Deferred Tax Liability Non Current | 3.44B | 1.8B | 871M | 1.39B | 1.44B | |||||
Other Non Current Liabilities | 6.34B | 6.09B | 6.63B | 4.65B | 5.95B | |||||
Total Liabilities | 67.44B | 63.1B | 69.04B | 70.73B | 84.2B | |||||
Common Stock, Total | 1.79B | 1.79B | 1.79B | 1.79B | 1.79B | |||||
Additional Paid In Capital | 44.24B | 44.38B | 44.51B | 44.7B | 45.03B | |||||
Retained Earnings | 53.7B | 61.08B | 53.9B | 63.07B | 73.08B | |||||
Treasury Stock | -57.11B | -56.49B | -57.45B | -58.3B | -63B | |||||
Comprehensive Income and Other | -4.43B | -4.77B | -5.16B | -4.94B | -4.29B | |||||
Total Common Equity | 38.18B | 45.99B | 37.58B | 46.31B | 52.61B | |||||
Minority Interest | 73M | 67M | 54M | 59M | 56M | |||||
Total Equity | 38.26B | 46.06B | 37.64B | 46.37B | 52.66B | |||||
Total Liabilities And Equity | 106B | 109B | 107B | 117B | 137B | |||||
Supplemental Items | ||||||||||
ECS Total Shares Outstanding on Filing Date | 2.53B | 2.54B | 2.53B | 2.53B | 2.47B | |||||
ECS Total Common Shares Outstanding | 2.53B | 2.54B | 2.53B | 2.53B | 2.47B | |||||
Book Value / Share | 15.11 | 18.12 | 14.84 | 18.32 | 21.26 | |||||
Tangible Book Value | -6.01B | 4.52B | -1.63B | 8.28B | 4.35B | |||||
Tangible Book Value Per Share | -2.38 | 1.78 | -0.64 | 3.27 | 1.76 | |||||
Total Debt | 34.63B | 31.98B | 36.27B | 38.27B | 50.53B | |||||
Net Debt | 26.52B | 18.79B | 29.18B | 24.58B | 35.97B | |||||
Debt Equivalent of Unfunded Proj. Benefit Obligation | 312M | 42M | 122M | -939M | -2.59B | |||||
Debt Equivalent Oper. Leases | 2.74B | 2.67B | 2.71B | 2.78B | 3.38B | |||||
Minority Interest, Total (Incl. Fin. Div) | 73M | 67M | 54M | 59M | 56M | |||||
Equity Method Investments, Total | - | - | - | - | - | |||||
Account Code - Inventory Valuation | 4 | 4 | 4 | 4 | 4 | |||||
LIFO Reserve, Total | -16M | -293M | -562M | -840M | -912M | |||||
Inventories - Raw Materials, Total | 4.03B | 4.12B | 4.69B | 4.64B | 4.96B | |||||
Inventories - Finished Goods, Total | 1.75B | 1.84B | 1.95B | 2.02B | 2.28B | |||||
Inventories - Others | 196M | 238M | 277M | 289M | 331M | |||||
Land - (BS) | 326M | 295M | 326M | 307M | 321M | |||||
Buildings, Total | 12.53B | 13.17B | 14.97B | 16.36B | 17.98B | |||||
Machinery, Total | 16.3B | 16.76B | 17.76B | 18.28B | 19.76B | |||||
Full Time Employees | 67K | 67K | 70K | 73K | 73K | |||||
Part Time Employees | 1K | 2K | 2K | 2K | 2K | |||||
Accumulated Allowance for Doubtful Accounts (Supple) | 62M | 72M | 88M | 89M | 97M |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















